VOICED : China exhibe por primera vez sus vacunas contra el coronavirus

Chinese vaccines by Sinovac and Sinopharm were showcased at a Beijing trade fair, raising expectations. They are in Phase 3 trials, with hopes for year-end efficacy data and authorization. Sinovac has built a plant to produce 300 million doses annually. Initial vaccinations will target high-risk groups, with broader inoculation based on epidemic needs. China faces criticism for its COVID-19 response, but vaccine development may improve its image. More information is available at ISGlobal.org.

What new insight or understanding did you gain from this video?